Spectrofluorimetric determination of anthranilic acid derivatives based on terbium sensitized fluorescence

被引:59
作者
Ioannou, PC [1 ]
Rusakova, NV
Andrikopoulou, DA
Glynou, KM
Tzompanaki, GM
机构
[1] Univ Athens, Analyt Chem Lab, GR-15771 Athens, Greece
[2] Natl Acad Sci Ukraine, AV Bogatskii Physicochem Inst, UA-270080 Odessa, Ukraine
关键词
D O I
10.1039/a806093b
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Terbium sensitized fluorescence was used to develop a sensitive and simple spectrofluorimetric method for the determination of the anthranilic acid derivatives furosemide and mefenamic and tolfenamic acids. The method makes use of radiative energy transfer from anthranilates to terbium ions in alkaline methanolic solutions. Optimum conditions for the formation of the anthranilate-Tb3+ complexes were investigated. Under optimized conditions, the detection limits are 6 x 10(-9), 1.4 x 10(-8) and 9.0 x 10-9 mol l(-1) for furosemide, mefenamic acids and tolfenamic acid, respectively. The range of application is 2.5 x 10(-8)-5.0 x 10(-5) mol l(-1) for all three drugs. The method was successfully applied to the determination of furosemide and mefenamic and tolfenamic acids in serum after extraction of the samples with ethyl acetate, evaporation of the organic layer under a stream of nitrogen at 40 degrees C and reconstitution of the residue with alkaline methanolic terbium solution prior to instrumental measurement The mean recoveries from serum samples spiked with furosemide (5.0 x 10(-7), 2.0 x 10(-6) and 8.0 x 10(-6) mol l(-1)), mefenamic acid (3.0 x 10-6, 9.0 x 10-6 and 3.0 x 10(-5) mol l(-1)) and tolfenamic acid (3.1 x 10(-6), 12.5 x 10(-6) and 2.5 x 10(-5) mol l(-1)) were 96 +/- 8, 101 +/- 5 and 98 +/- 7%, respectively. The within-run precision (RSD) for the method for two serum samples of each drug varied from 2 to 8% and the day-to-day precision for two concentration levels varied from 2 to 13%.
引用
收藏
页码:2839 / 2843
页数:5
相关论文
共 30 条
[1]   FLOW-INJECTION SPECTROFLUOROMETRIC DETERMINATION OF FLUFENAMIC AND MEFENAMIC-ACID IN PHARMACEUTICALS [J].
ALBERO, MI ;
SANCHEZPEDRENO, C ;
GARCIA, MS .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (09) :1113-1117
[2]   KINETICS AND DYNAMICS OF FUROSEMIDE AND SLOW-ACTING FUROSEMIDE [J].
BEERMANN, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (05) :584-591
[3]  
Bortolin S, 1996, CLIN CHEM, V42, P1924
[4]  
BUENO CR, 1991, ARCH MED DEPORTE, V3, P411
[5]   SIMPLIFIED ASSAY OF FUROSEMIDE IN PLASMA AND URINE BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
CARR, K ;
RANE, A ;
FROLICH, JC .
JOURNAL OF CHROMATOGRAPHY, 1978, 145 (03) :421-427
[6]  
Christopoulos Theodore K., 1996, P309, DOI 10.1016/B978-012214730-2/50015-7
[7]   EUROPIUM AND TERBIUM CHELATORS AS CANDIDATE SUBSTRATES FOR ENZYME-LABELED TIME-RESOLVED FLUOROMETRIC IMMUNOASSAYS [J].
DIAMANDIS, EP .
ANALYST, 1992, 117 (12) :1879-1884
[8]   EUROPIUM CHELATE LABELS IN TIME-RESOLVED FLUORESCENCE IMMUNOASSAYS AND DNA HYBRIDIZATION ASSAYS [J].
DIAMANDIS, EP ;
CHRISTOPOULOS, TK .
ANALYTICAL CHEMISTRY, 1990, 62 (22) :A1149-+
[9]  
DICKSON EFG, 1995, PHARMACOL THERAPEUT, V66, P207
[10]   LANTHANIDE-SENSITIZED LUMINESCENCE AND APPLICATIONS TO THE DETERMINATION OF ORGANIC ANALYTES - A REVIEW [J].
GEORGES, J .
ANALYST, 1993, 118 (12) :1481-1486